Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |